Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeiq Regulatory News (HEIQ)

  • There is currently no data for HEIQ

Board Appointment

27 Nov 2023 07:00

RNS Number : 6712U
HeiQ PLC
27 November 2023
 

27 November 2023

HeiQ Plc

("HeiQ" or "the Company")

Board Appointment

 

HeiQ (LSE:HEIQ), a leading company in materials innovation and hygiene technologies, is pleased to announce the appointment of Robert van de Kerkhof as Non-Executive Director, with effect from 1 January 2024, to the board of HeiQ plc and as Chairman of the Environmental, Occupation, Health & Safety and Sustainability Committee. Robert will also be appointed to the board of HeiQ AeoniQ Holding AG (in Switzerland), a subsidiary of HeiQ plc.

 

Robert has over 30 years of experience in general management and sustainability leadership and extensive knowledge of the textiles industry, including cellulosic fiber technology. He is the founder of PEPPER-i2, an advisory company specializing in sustainability and circularity. Robert also serves as the Chief Sustainability Officer and as a Board Member, a position he has held since 2014, of Lenzing AG (ATX listed LNZ.VI). Robert will be leaving Lenzing and its Board on 31 December 2023.

 

Robert joins HEIQ AeoniQ with the firm belief that the novel HEIQ AeoniQ man-made cellulosic fibers (MMCF) are one of the most promising solutions to decarbonizing the textile industry and achieving a path to net zero for brands.

 

Robert has also held senior positions as President of the Austrian Fiber Institute, President and Board Member of CIRFS - the European Man-made Fibres Association, and Chairman of the ReHubs Business Council for Euratex, which is the voice of the European Apparel and Textile Industry. These roles further demonstrate his strong leadership experience and expertise within the textiles industry.

 

Esther Dale-Kolb, Non-Executive Director and Chair of HeiQ plc, commented: "I would like to welcome Robert to the HeiQ board as Non-Executive Director. His extensive experience and proven track record in leadership, sustainability and innovation are well aligned with HeiQ's vision for the future."

 

Robert van de Kerkhof, HeiQ plc Non-Executive Director, commented: "I am delighted to be joining the Board of HeiQ. I am confident that the Company is on the right course and I look forward to helping it advance its commitment to delivering innovative textile solutions that positively impact the industry. In particular, I firmly believe the Company's novel HEIQ AeoniQ MMCF fibers are one of the most promising solutions to decarbonizing the textiles industry and achieving a path to net zero for brands."

 

 

 

For further information, please contact:

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Cavendish Securities plc (Broker)

Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Molly Gretton / Tom Carnegie

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

 

About HeiQ

HeiQ is a Swiss-based international company that innovates pioneering and differentiating materials in partnership with established global brands. We bridge the academic and commercial worlds to conceive performance-enhancing materials and technologies, working with aligned brands to research, manufacture and bring products to market, aiming for lab to consumer in months. Our goal is to improve the lives of billions by innovating the materials that go into everyday products, making them more hygienic, comfortable, protective, and sustainable.

Our strong IP portfolio positions us as an innovation leader for niche, premium and high-margin products in the textile chemicals, man-made fibers, paints and coatings, antimicrobial plastics, probiotics and household cleaner markets. We have also expanded into healthcare facilities, probiotic cleaning, and hygiene coatings markets to help make hospitals and healthcare environments more hygienic.

We have developed over 200 technologies in partnership with 300 major brands. With a substantial research and development pipeline, including key technology development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ GrapheneX, and HeiQ Synbio, HeiQ aims to deliver shareholder value through sales growth and entry into new lucrative markets through disruptive innovation and M&A.

We have built a strong reputation for ESG & sustainable innovation, having won multiple awards including the Swiss Technology Award twice and the Swiss Environmental Award. Under experienced leadership, we are committed to driving our profit in close connection with people and the planet. For more information, please visit www.heiq.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADQLFLXFLFFBE
Date   Source Headline
2nd Dec 20227:00 amRNSAcquisition of Chem-Tex Laboratories, Inc
7th Nov 20227:00 amRNSChange of Auditor
10th Oct 20227:00 amRNSFiles Breach of Exclusive Agreement Complaint
13th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSNotice of H1 2022 Results and Presentation
8th Aug 202210:33 amRNSIssue of Equity and Total Voting Rights
29th Jun 202211:06 amRNSResult of AGM
14th Jun 20227:00 amRNSCommercial progress of HeiQ’s Hygiene technologies
18th May 20227:00 amRNSNotice of AGM
12th May 20227:00 amRNSPayment of Earnout Consideration
28th Apr 20227:00 amRNSResults for the year ended 31 December 2021
14th Apr 20227:00 amRNSFY 2021 Trading Update and Notice of Results
24th Feb 20222:55 pmRNSIssue of Equity
17th Feb 20222:35 pmRNSDirector/PDMR Shareholding
14th Feb 20227:00 amRNSHUGO BOSS and LYCRA back new climate positive yarn
3rd Dec 20217:00 amRNSInvestor Presentation
28th Sep 20219:05 amRNSSecond Price Monitoring Extn
28th Sep 20219:00 amRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
20th Sep 20217:00 amRNSNotice of Results and Investor Presentation
16th Jul 20217:00 amRNSCollaboration Agreement with The LYCRA Company
9th Jul 20217:00 amRNSCompletion of Acquisition
28th Jun 20211:45 pmRNSFurther re. Annual General Meeting
25th Jun 20214:40 pmRNSResult of AGM
21st Jun 20214:30 pmRNSAnnual General Meeting Update
15th Jun 20217:00 amRNSAcquisition Life Material Technologies Limited
9th Jun 20217:00 amRNSHeiQ Chrisal water treatment solution contract win
28th May 20217:00 amRNSCreates sustainable textile finishing partnership
20th May 20214:20 pmRNSProgressive initiates coverage
13th May 20217:00 amRNSNotice of AGM
29th Apr 20217:00 amRNSAcquisition of RAS AG
28th Apr 20217:00 amRNSResults for the year ended December 31, 2020
8th Apr 20217:00 amRNSNotice of Results and Investor Presentation
19th Mar 20217:00 amRNSHeiQ Viroblock Agreement with ICP
11th Mar 20217:00 amRNSHeiQ Viroblock Partnership with Berger Paint
3rd Mar 20217:00 amRNSAcquisition of 51% of Industrial Biotech Business
11th Feb 20217:00 amRNSHeiQ Viroblock Contract Win
28th Jan 202111:30 amRNSLaunch of HeiQ Viroblock Permanent
27th Jan 20219:05 amRNSSecond Price Monitoring Extn
27th Jan 20219:00 amRNSPrice Monitoring Extension
26th Jan 20219:05 amRNSSecond Price Monitoring Extn
26th Jan 20219:00 amRNSPrice Monitoring Extension
26th Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSChange of External Auditor
5th Jan 20212:01 pmRNSPrice Monitoring Extension
4th Jan 20219:05 amRNSSecond Price Monitoring Extn
4th Jan 20219:00 amRNSPrice Monitoring Extension
15th Dec 20207:00 amRNSMajority stake in medical device manufacturer
9th Dec 202011:15 amRNSDirector/PDMR Dealings
9th Dec 20207:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.